Dosimetry and treatment planning of Occu-Prosta I-125 seeds for intraocular lesions
Intraocular malignant lesions are frequently encountered in clinical practice. Plaque brachytherapy represents an effective means of treatment for intraocular lesions. Recently Radiopharmaceutical Division, BARC, Mumbai, has indigenously fabricated reasonable-cost I-125 sources. Here we are presenti...
Main Authors: | Chaudhari Suresh, Deshpande Sudesh, Anand Vivek, De Sandeep, Saxena Sanjay, Dash A, Basu Mahua, Samant Preetam, Kannan V |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2008-01-01
|
Series: | Journal of Medical Physics |
Subjects: | |
Online Access: | http://www.jmp.org.in/article.asp?issn=0971-6203;year=2008;volume=33;issue=1;spage=14;epage=18;aulast=Chaudhari |
Similar Items
-
Episcleral plaque brachytherapy using ′BARC I-125 Ocu-Prosta seeds′ in the treatment of intraocular tumors: A single-institution experience in India
by: Parag K Shah, et al.
Published: (2012-01-01) -
Dosimetry Comparison of Water Phantom and Complete Eye Definition for 125I and 103Pd Brachytherapy Plaques
by: Zohreh Dehghannia Rostami, et al.
Published: (2011-06-01) -
Annulus-shaped I-125 plaque brachytherapy for conjunctival melanoma
by: Sean T. Berkowitz, et al.
Published: (2022-06-01) -
Brachytherapy of intra ocular tumors using ′BARC I-125 Ocu-Prosta seeds′: An Indian experience
by: Vikas Khetan, et al.
Published: (2014-01-01) -
Determination of the Dosimetric Characteristics of BATAN’s 125I Source for Brachytherapy: An Experimental Study
by: K.Y.P. Sandy, et al.
Published: (2018-08-01)